Catheter Precision (VTAK) announced that its LockeT suture retention device will be highlighted during live procedural cases at the Structural Heart Intervention and Imaging: A Practical Approach 2026 conference. The event, hosted by Scripps Health, will take place from February 11-13, 2026, at the Hyatt Regency La Jolla at Aventine in San Diego. “We are honored to have LockeT showcased at such a prestigious clinical gathering,” said David Jenkins, CEO of Catheter Precision. “As we enter 2026 with strong momentum and expansion into major medical centers like Scripps in Southern California, these live cases provide a vital platform for physicians to witness firsthand the operational and economic advantages of our suture retention technology.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision announces accelerated momentum for LockeT device
- Catheter Precision receives first purchase order for LockeT in Germany
- Catheter Precision receives new VIVO purchase order from hospital in Slovenia
- Catheter Precision Extends Insider Short-Term Debt Maturities
- Catheter Precision announces expansion of LockeT into eight European country
